Pfizer
US politicians unite to flay Pfizer-Allergan deal
24 Nov 2015
Democratic presidential front-runner Hillary Clinton said the deal would “leave US taxpayers holding the bag”, while her Republican rival Donald Trump called it “disgusting”
Pfizer to take over Allergan in historic $150-bn deal
23 Nov 2015
The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire
Pfizer said to be in $150-bn merger talks with Allergan
19 Nov 2015
Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion
Pfizer, Allergan mull largest pharma merger
29 Oct 2015
US drug giant Pfizer Inc and Irish pharmaceutical company Allergan Plc are weighing a merger plan, which would create the world’s largest drug company with a market cap of more than $300 billion
Indian Patent Office rejects Pfizer's claim for arthritis drug patent
07 Sep 2015
The Indian Patent Office has rejected a patent application by pharma multinational Pfizer Inc for its rheumatoid arthritis drug `Tofacitinib’ for failing to prove its efficacy over its original version for which patent protection is ending
Pfizer is unnamed bidder for Swedish rare disease firm Orphan Biovitrum
02 May 2015
Pfizer’s interest in rare diseases first became evident in December 2009, when the company licensed the worldwide rights to taliglucerase alfa, a product that treats the genetic disorder Gaucher disease
